Loading...
Ibrutinib
India Pharmaceutical Trade Intelligence
Who Supplies Ibrutinib to India from UNITED STATES
India's ibrutinib imports from UNITED STATES total $961.1K across 17 shipments from 10 foreign suppliers. PHARMACEUTICAL BUYERS,INC. leads with $392.9K in import value; the top 5 suppliers together control 84.1% of this origin. Leading Indian buyers include MYLAN LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for ibrutinib — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
PHARMACEUTICAL BUYERS,INC. is the leading Ibrutinib supplier from UNITED STATES to India, with import value of $392.9K across 4 shipments. The top 5 suppliers — PHARMACEUTICAL BUYERS,INC., PHARMACEUTICAL BUYERS,INC, ESPEE BIOPHARMA AND FINECHEM LLC, NEW LIFE MEDICALS (USA), INC., PHARMACEUTICALS BUYERS INC — collectively account for 84.1% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL BUYERS,INC. | $392.9K | 4 | 40.9% |
| 2 | PHARMACEUTICAL BUYERS,INC | $126.3K | 1 | 13.1% |
| 3 | ESPEE BIOPHARMA AND FINECHEM LLC | $102.5K | 3 | 10.7% |
| 4 | NEW LIFE MEDICALS (USA), INC. | $97.6K | 2 | 10.2% |
| 5 | PHARMACEUTICALS BUYERS INC | $89.3K | 1 | 9.3% |
| 6 | M/S PHARMACEUTICAL BUYERS, INC. | $67.3K | 1 | 7.0% |
| 7 | PHARMACEUTICAL BUYERS INC | $36.3K | 1 | 3.8% |
| 8 | NEW LIFE MEDICALS (USA) INC., | $24.6K | 1 | 2.6% |
| 9 | NEW LIFE MEDICALS (USA) INC. | $24.2K | 1 | 2.5% |
| 10 | AMNEAL COMPLEX PRODUCTS RESEARCH LLC | $1 | 2 | 0.0% |
Showing top 10 of 10 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $519.2K | 5 | 54.0% |
| 2 | ZENRISE CLINICAL RESEARCH PRIVATE LIMITED | $125.6K | 2 | 13.1% |
| 3 | USV PRIVATE LIMITED | $102.5K | 3 | 10.7% |
| 4 | INTAS PHARMACEUTICALS LIMITED | $97.6K | 2 | 10.2% |
| 5 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $67.3K | 1 | 7.0% |
| 6 | ZYDUS LIFESCIENCES LIMITED | $48.9K | 2 | 5.1% |
| 7 | VEEDA CLINICAL RESEARCH PRIVATE LIMITED | $1 | 2 | 0.0% |
Import Statistics
- Import Value
- $961.1K
- Shipments
- 17
- Foreign Suppliers
- 10
- Indian Buyers
- 7
- Avg. Shipment
- $56.5K
Other Ibrutinib Import Origins
Frequently Asked Questions — Ibrutinib Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Ibrutinib suppliers from UNITED STATES to India?
The top Ibrutinib suppliers from UNITED STATES to India include PHARMACEUTICAL BUYERS,INC., PHARMACEUTICAL BUYERS,INC, ESPEE BIOPHARMA AND FINECHEM LLC. The leading supplier is PHARMACEUTICAL BUYERS,INC. with import value of $392.9K USD across 4 shipments. India imported Ibrutinib worth $961.1K USD from UNITED STATES in total across 17 shipments.
QHow much Ibrutinib does India import from UNITED STATES?
India imported Ibrutinib worth $961.1K USD from UNITED STATES across 17 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Ibrutinib from UNITED STATES?
The main Indian buyers of Ibrutinib sourced from UNITED STATES include MYLAN LABORATORIES LIMITED, ZENRISE CLINICAL RESEARCH PRIVATE LIMITED, USV PRIVATE LIMITED. The largest buyer is MYLAN LABORATORIES LIMITED with $519.2K in imports across 5 shipments.
QWhat is the total value of Ibrutinib imports from UNITED STATES to India?
The total value of Ibrutinib imports from UNITED STATES to India is $961.1K USD, across 17 shipments and 10 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Ibrutinib.
- 2.Supplier/Buyer Matching: 10 foreign suppliers from UNITED STATES and 7 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $961.1K aggregated from 17 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
17 Verified Shipments
10 suppliers, 7 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists